BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 897662)

  • 41. Inhibition of uterine estrogen receptor transformation by sodium molybdate.
    Shyamala G; Leonard L
    J Biol Chem; 1980 Jul; 255(13):6028-31. PubMed ID: 7391003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-estrogen interaction with uterine estrogen receptors. Studies with a radiolabeled anti-estrogen (CI-628).
    Katzenellenbogen BS; Katzenellenbogen JA; Ferguson ER; Krauthammer N
    J Biol Chem; 1978 Feb; 253(3):697-707. PubMed ID: 621199
    [No Abstract]   [Full Text] [Related]  

  • 43. The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions.
    Nicholson RI; Syne JS; Daniel CP; Griffiths K
    Eur J Cancer (1965); 1979 Mar; 15(3):317-29. PubMed ID: 446514
    [No Abstract]   [Full Text] [Related]  

  • 44. Estrogen receptors in cultured rat uterine cells: induction of progesterone receptors in the absence of estrogen receptor processing.
    Kassis JA; Walent JH; Gorski J
    Endocrinology; 1986 Feb; 118(2):603-8. PubMed ID: 3943487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone: effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus.
    Attardi B
    Endocrinology; 1981 Apr; 108(4):1487-96. PubMed ID: 7472278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen action in the mouse uterus: characterization of the cytosol and nuclear receptor systems.
    Korach KS
    Endocrinology; 1979 May; 104(5):1324-32. PubMed ID: 436778
    [No Abstract]   [Full Text] [Related]  

  • 47. Characterization of an antiidiotypic antibody mimicking the actions of estradiol and its interaction with estrogen receptors.
    Mor G; Amir-Zaltsman Y; Barnard G; Kohen F
    Endocrinology; 1992 Jun; 130(6):3633-40. PubMed ID: 1597160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of estrogen binding in uterine cytosol from the fetal rhesus monkey.
    Kimmel GL; Harmon JR; Slikker W
    Teratog Carcinog Mutagen; 1983; 3(4):355-65. PubMed ID: 6138868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The alpha 1-noradrenergic antagonist prazosin decreases the concentration of estrogen receptors in female rat hypothalamus.
    Blaustein JD
    Brain Res; 1987 Feb; 404(1-2):39-50. PubMed ID: 2882810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular and functional anomalies in the mechanism of the estrogenic action of 4-mercuri-17 beta-estradiol.
    Muldoon TG
    J Biol Chem; 1980 Feb; 255(4):1358-66. PubMed ID: 7354031
    [No Abstract]   [Full Text] [Related]  

  • 51. The binding of rat uterine cytosol oestrogen receptor to oligothymidylate-cellulose: further evidence for the presence of a cytosol activating factor [proceedings].
    Myatt L; Elder MG; Lim L
    Biochem Soc Trans; 1979 Oct; 7(5):909-10. PubMed ID: 510738
    [No Abstract]   [Full Text] [Related]  

  • 52. Determination of cytosol and nuclear estradiol-binding sites in fetal guinea pig uterus by [3H]estradiol exchange.
    Sumida C; Pasqualini JR
    Endocrinology; 1979 Aug; 105(2):406-13. PubMed ID: 456319
    [No Abstract]   [Full Text] [Related]  

  • 53. Estrogen receptor binding affinity and uterotrophic activity of triphenylhaloethylenes.
    DeSombre ER; Mease RC; Sanghavi J; Singh T; Seevers RH; Hughes A
    J Steroid Biochem; 1988 Jun; 29(6):583-90. PubMed ID: 3386226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Steroid receptor forms and their interaction with cytoplasmic modulators.
    Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
    J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiation of estradiol receptors in rat uterine cytosol by sensitivity to tamoxifen.
    Fishman JH; Fishman J
    Biochem Biophys Res Commun; 1979 Mar; 87(2):550-8. PubMed ID: 444239
    [No Abstract]   [Full Text] [Related]  

  • 56. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The thermolability of rat uterine cytosol estrogen receptors: basis for a novel cytosol exchange-denaturation assay.
    Woosley JT; Muldoon TG
    J Steroid Biochem; 1979 Aug; 11(2):1065-71. PubMed ID: 502549
    [No Abstract]   [Full Text] [Related]  

  • 58. Ribosome-associated estradiol-binding components in the uterus and their relationship to the translational capacity of uterine ribosomes.
    Labate ME; Whelly SM; Barker KL
    Endocrinology; 1986 Jul; 119(1):140-51. PubMed ID: 3720662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chloro-s-triazine antagonism of estrogen action: limited interaction with estrogen receptor binding.
    Tennant MK; Hill DS; Eldridge JC; Wetzel LT; Breckenridge CB; Stevens JT
    J Toxicol Environ Health; 1994 Oct; 43(2):197-211. PubMed ID: 7932849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of immunoassayable estrogen receptor lacking hormone binding ability in tamoxifen-treated rat uterus.
    Nakao M; Sato B; Koga M; Noma K; Kishimoto S; Matsumoto K
    Biochem Biophys Res Commun; 1985 Oct; 132(1):336-42. PubMed ID: 3904747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.